PRADAXIS Trademark

Trademark Overview


On Thursday, November 14, 2024, a trademark application was filed for PRADAXIS with the United States Patent and Trademark Office. The USPTO has given the PRADAXIS trademark a serial number of 98852979. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, May 9, 2025. This trademark is owned by Pradaxis, Inc.. The PRADAXIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; Medical research; Medical and scientific research in the field of drug discovery; Research and development of medicines
pradaxis

General Information


Serial Number98852979
Word MarkPRADAXIS
Filing DateThursday, November 14, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, May 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDrug discovery services; Medical research; Medical and scientific research in the field of drug discovery; Research and development of medicines

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 14, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePradaxis, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCelebration, FL 34747

Trademark Events


Event DateEvent Description
Thursday, November 14, 2024NEW APPLICATION ENTERED
Saturday, April 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 9, 2025ASSIGNED TO EXAMINER
Friday, May 9, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 9, 2025NON-FINAL ACTION WRITTEN
Friday, May 9, 2025NON-FINAL ACTION E-MAILED